Brücke T - Search Results

1

Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.

Presslauer S, Milosavljevic D, Brücke T, Bayer P, Hübl W. Presslauer S, et al. Among authors: brucke t. J Neurol. 2008 Oct;255(10):1508-14. doi: 10.1007/s00415-008-0954-z. Epub 2008 Jul 17. J Neurol. 2008. PMID: 18685917

2

Dopamine D2 receptor imaging and measurement with SPECT.

Brücke T, Wenger S, Asenbaum S, Fertl E, Pfafflmeyer N, Müller C, Podreka I, Angelberger P. Brücke T, et al. Adv Neurol. 1993;60:494-500. Adv Neurol. 1993. PMID: 8420177

3

Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.

Timmermann L, Jain R, Chen L, Maarouf M, Barbe MT, Allert N, Brücke T, Kaiser I, Beirer S, Sejio F, Suarez E, Lozano B, Haegelen C, Vérin M, Porta M, Servello D, Gill S, Whone A, Van Dyck N, Alesch F. Timmermann L, et al. Among authors: brucke t. Lancet Neurol. 2015 Jul;14(7):693-701. doi: 10.1016/S1474-4422(15)00087-3. Epub 2015 May 28. Lancet Neurol. 2015. PMID: 26027940

4

Long-term effects of STN DBS on mood: psychosocial profiles remain stable in a 3-year follow-up.

Kaiser I, Kryspin-Exner I, Brücke T, Volc D, Alesch F. Kaiser I, et al. Among authors: brucke t. BMC Neurol. 2008 Nov 11;8:43. doi: 10.1186/1471-2377-8-43. BMC Neurol. 2008. PMID: 19014430 Free PMC article. Clinical Trial.

5

Acute porphyric neuropathy during pregnancy--effect of haematin therapy.

Wenger S, Meisinger V, Brücke T, Deecke L. Wenger S, et al. Among authors: brucke t. Eur Neurol. 1998;39(3):187-8. doi: 10.1159/000007932. Eur Neurol. 1998. PMID: 9605398 No abstract available.

6

Fatal familial insomnia: a new Austrian family.

Almer G, Hainfellner JA, Brücke T, Jellinger K, Kleinert R, Bayer G, Windl O, Kretzschmar HA, Hill A, Sidle K, Collinge J, Budka H. Almer G, et al. Among authors: brucke t. Brain. 1999 Jan;122 ( Pt 1):5-16. doi: 10.1093/brain/122.1.5. Brain. 1999. PMID: 10050890

7

SPECT and PET imaging of the dopaminergic system in Parkinson's disease.

Brücke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I. Brücke T, et al. J Neurol. 2000 Sep;247 Suppl 4:IV/2-7. doi: 10.1007/pl00007769. J Neurol. 2000. PMID: 11199811 Review.

8

In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.

Brücke T, Tsai YF, McLellan C, Singhanyom W, Kung HF, Cohen RM, Chiueh CC. Brücke T, et al. Life Sci. 1988;42(21):2097-104. doi: 10.1016/0024-3205(88)90123-3. Life Sci. 1988. PMID: 3260318

9

Terguride: partial dopamine agonist in the treatment of Parkinson's disease.

Brücke T, Danielczyk W, Simányi M, Sofic E, Riederer P. Brücke T, et al. Adv Neurol. 1987;45:573-6. Adv Neurol. 1987. PMID: 3825735

10

Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's disease.

Barbe MT, Barthel C, Chen L, Van Dyck N, Brücke T, Seijo F, San Martin ES, Haegelen C, Verin M, Amarell M, Gill S, Whone A, Porta M, Servello D, Fink GR, Alesch F, Bloem BR, Timmermann L. Barbe MT, et al. Among authors: brucke t. Brain Stimul. 2018 Nov-Dec;11(6):1404-1406. doi: 10.1016/j.brs.2018.08.016. Epub 2018 Aug 27. Brain Stimul. 2018. PMID: 30174201 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results